| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/17/2008 | EP1969000A2 Cell penetrating peptides for intracellular delivery of molecules |
| 09/17/2008 | EP1968706A2 Development of novel antibiotic alternatives |
| 09/17/2008 | EP1968646A2 A predictive tool for hyaluronidase treatment success |
| 09/17/2008 | EP1968645A2 Human glp-1 mimetibodies and compositions for treating obesity and related disorders, methods and uses |
| 09/17/2008 | EP1968635A2 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides |
| 09/17/2008 | EP1968628A2 Transferrin and transferrin-based compositions for diabetes treatment |
| 09/17/2008 | EP1968627A2 Compositions for disrupting and inhibiting reconstitution of wound biofilm |
| 09/17/2008 | EP1968626A1 Thrombin-free biological adhesive and use thereof as a medicament |
| 09/17/2008 | EP1968625A2 New chemokine antagonists |
| 09/17/2008 | EP1968624A2 Treatment of hiv |
| 09/17/2008 | EP1968623A2 Bacteriocin inducer peptides |
| 09/17/2008 | EP1968622A2 Microrna expression abnormalities in pancreatic endocrine and acinar tumors |
| 09/17/2008 | EP1968621A2 Uses of myostatin antagonists |
| 09/17/2008 | EP1968589A2 Combinations comprising sorafenib and interferon for the treatment of cancer |
| 09/17/2008 | EP1968549A1 Sustained release formulation comprising octreotide and two or more polylactide-co-glycolide polymers |
| 09/17/2008 | EP1968538A1 Pharmaceutical compositions comprising cyclosporin |
| 09/17/2008 | EP1732939A4 Nucleic acid based assays for identification of fc receptor polymorphisms |
| 09/17/2008 | EP1673070A4 Preparation method for sustained release microspheres using a dual-feed nozzle |
| 09/17/2008 | EP1563071B1 Protein specific to pancreatic beta cells in islets of langerhans and applications thereof |
| 09/17/2008 | EP1503790B1 Intracranial treatment of neuropsychiatric disorders by clostridial neurotoxins such as botulinum toxin |
| 09/17/2008 | EP1463525B1 Compositions and methods for the diagnosis and treatment of tumor |
| 09/17/2008 | EP1411968B1 Glp-1 exendin-4 peptide analogs and uses thereof |
| 09/17/2008 | EP1409692B1 Novel peptides of the respiratory syncytial virus (rsv) g protein and their use in a vaccine |
| 09/17/2008 | EP1392639B1 Pyruvate derivatives |
| 09/17/2008 | EP1305334B1 Urocortin proteins and uses thereof |
| 09/17/2008 | EP1297838B1 Pralmorelin-containing nasal drop preparations |
| 09/17/2008 | EP1296554B1 Prevention and treatment of mycoplasma-associated diseases using trans-sialidase and/or neuraminidase |
| 09/17/2008 | EP1284999B1 Repair of nerve damage |
| 09/17/2008 | EP1253941B1 Pre-transplant accommodated organs resistant to anti-donor immunity |
| 09/17/2008 | EP1202748B1 Polycation-based bioconjugates |
| 09/17/2008 | EP1202736B1 Nicotine in therapeutic angiogenesis and vasculogenesis |
| 09/17/2008 | EP1141331B1 HUMAN CYCLIN-DEPENDENT KINASE (hPNQALRE) |
| 09/17/2008 | EP1121434B1 Polypeptides for modulating cell survival |
| 09/17/2008 | EP1076697B1 Semaphorin polypeptides |
| 09/17/2008 | EP1074264B1 Neovascularization inhibitors |
| 09/17/2008 | EP1062341B1 Mutant recombinant allergens |
| 09/17/2008 | EP1036095B1 Oxygen-transporting albumin-based blood replacement composition and blood volume expander |
| 09/17/2008 | EP1017714B1 SYNTHETIC PEPTIDE CONSTRUCTS FOR THE DIAGNOSIS AND TREATMENT OF PERIODONTITIS ASSOCIATED WITH $i(PORPHYROMONAS GINGIVALIS) |
| 09/17/2008 | EP1003854B1 Antimicrobial peptides derived from ubiquicidine |
| 09/17/2008 | EP0917877B1 Remedies/preventives for viral infections, process for preparing the same, and method for preventing/treating viral infections |
| 09/17/2008 | EP0832116B1 New dna molecules |
| 09/17/2008 | CN101268190A Delta 6 desaturase from thraustochytrid and uses thereof |
| 09/17/2008 | CN101268102A Tissue inhibitor of metalloproteinases (TIMP) linked to glycosylphosphatidylinositol (GPI) -anchors for treatment of cancer and skin lesions |
| 09/17/2008 | CN101268100A Modified leukocyte ig-like receptor family members (LIR'S) with increased affinity for class I MHC and their uses in modulating T cell activation |
| 09/17/2008 | CN101268099A Y4 selective receptor agonists for therapeutic interventions |
| 09/17/2008 | CN101268098A Liquid formulations of pegylated growth hormone |
| 09/17/2008 | CN101268096A Y2 selective receptor agonists for therapeutic interventions |
| 09/17/2008 | CN101268093A Age inhibitors |
| 09/17/2008 | CN101267832A Platelet aggregation inhibitor and health food effective in inhibiting platelet aggregation |
| 09/17/2008 | CN101267831A Compositions and methods for promoting hemostasis and other physiological activities |
| 09/17/2008 | CN101267830A Growth hormone secretagogues |
| 09/17/2008 | CN101267829A Thrombospondin-1 derived peptides and treatment methods |
| 09/17/2008 | CN101267805A Systems and methods for manufacturing liposomes |
| 09/17/2008 | CN101265300A Small molecule recombination toxin GnRH-luffinS2 fusion albumen and its preparation and application |
| 09/17/2008 | CN101265299A Biologically active peptides from functional domains of bactericidal permeability-increasing protein and uses thereof |
| 09/17/2008 | CN101265298A Endothelium chalone mutant containing non-natural amino acid and derivatives thereof |
| 09/17/2008 | CN101265297A Alpha-synapse nucleoprotein and Sph1 interactive condition site and application thereof in screening Parkinson's disease medicament |
| 09/17/2008 | CN101265296A Reptile cathelicidin antibiotic peptide and derivatives, and application thereof |
| 09/17/2008 | CN101265292A Polypeptides substances, preparing method and use thereof |
| 09/17/2008 | CN101265291A Recombination pig origin antibiotic peptide PG4 and its biological synthesis method and application |
| 09/17/2008 | CN101265290A Peptide containing tryptophyl-lysyl(arginyl) fragment and anticancer use thereof |
| 09/17/2008 | CN101264331A New purpose of Chinese medicine almond |
| 09/17/2008 | CN101264321A Use of transglutaminase |
| 09/17/2008 | CN101264320A Oxygen-carrying blood substitute preparations |
| 09/17/2008 | CN101264319A Preparation of exenatide freeze-drying preparation |
| 09/17/2008 | CN101264318A Virosis vaccine oral liquid for livestock, poultry and marine lives animal and preparation thereof |
| 09/17/2008 | CN101264317A Preparation of orally-administered protolysate |
| 09/17/2008 | CN101264316A Preparation of medicinal protolysate |
| 09/17/2008 | CN101264307A Common ginger root compound peptide composition and preparation thereof |
| 09/17/2008 | CN101263861A Preparation animal protolysate |
| 09/17/2008 | CN100419079C Compositions and methods for therapy and diagnosis of prostate cancer |
| 09/17/2008 | CN100419078C Expression method of glucosal related protein and application thereof |
| 09/17/2008 | CN100419060C Vigorous wine and preparation method thereof |
| 09/17/2008 | CN100418981C Gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 09/17/2008 | CN100418980C Process for purifying glycopeptide phospohonate derivatives |
| 09/17/2008 | CN100418955C Novel Benzo-fused heterocycles |
| 09/17/2008 | CN100418619C Injectable hydrogel microspheres from aqueous two-phase system |
| 09/17/2008 | CN100418575C Compound calcium preparation for astronaut |
| 09/17/2008 | CN100418574C chromatin peptide for blocking human HIF-1 alpha gene and regulating network downstream related gene |
| 09/16/2008 | US7425616 Use of C-reactive protein to treat immune complex-mediated renal disease |
| 09/16/2008 | US7425610 Expression vector comprising nucleotide sequences coding novel receptor protein for use in prevention and treatment of cell proliferative and autoimmune disorders |
| 09/16/2008 | US7425609 PRO4330 polypeptides |
| 09/16/2008 | US7425607 One or more lung tumor polypeptides and a carrier or immunostimulant; therapy and diagnosis of cancer, especially lung cancer |
| 09/16/2008 | US7425576 3-Azabicyclo[3.1.0]hexane-amide derivatives; human T-cell leukemia/lymphoma and lymphadenopathy associated virus, AIDS, cytomegalovirus (CMV) and Epstein-Barr virus (EBV), liver disease such as alcoholism and primary biliar cirrhosis |
| 09/16/2008 | US7425549 Drug for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis |
| 09/16/2008 | US7425547 Nucleoside derivatives for treating hepatitis C virus infection |
| 09/16/2008 | US7425544 Modulation of eIF4E expression |
| 09/16/2008 | US7425542 For reducing aggregation or immunogenicity of growth hormone including growth hormone; a buffering agent; and dodecyl maltoside, tridecyl maltoside, sucrose monododecanoate, sucrose monotridecanoate, or sucrose monotetradecanoate. |
| 09/16/2008 | US7425541 Therapy of tumors; prodrugs that display a high specificity of action, a reduced toxicity, and an improved stability in blood |
| 09/16/2008 | US7425540 Method for modification of NMDA receptors through inhibition of Src |
| 09/16/2008 | US7425539 Caused by the presence of factor VIII inhibitors in the blood; proteolytic activation of recombinantly-produced Factor IX; dissolving a paste of Cohn fraction IV-1, adsorbing onto calcium phosphate, eluting and applying to an anion exchange resin, eluting prekallikrein impurities and then factor IXa |
| 09/16/2008 | US7425538 HAUSP-p53 interaction and uses thereof |
| 09/16/2008 | US7425537 Macrocyclic peptide prevent binding with phosphoprotein; cancer therapy; angiogenesis inhibitor |
| 09/16/2008 | US7425536 Feline hepatocyte growth factor |
| 09/16/2008 | US7425535 Therapeutic pore-forming peptides |
| 09/16/2008 | US7425534 Compositions and methods for modulating muscle cell and tissue contractility |
| 09/16/2008 | US7425533 Modified hirudin proteins and T-cell epitopes in hirudin |
| 09/16/2008 | US7425532 Use of alanyl aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors |
| 09/16/2008 | US7425531 Administering bone polypeptide-1 expressed by a nucleic acid for treating a bone disorder or osteoporosis of a patient |
| 09/16/2008 | US7425530 Stereoselective preparation of cyclic L-amino acids |